BTMD: biote Corp. Stock

by  •  • Comments Off on BTMD: biote Corp. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 195.65
Enterprise Value ($M) 212.38
Book Value ($M) -36.55
Book Value / Share -1.06
Price / Book -5.35
NCAV ($M) -69.50
NCAV / Share -2.01
Price / NCAV -2.82

Profitability (mra)
Return on Invested Capital (ROIC) 0.04
Return on Assets (ROA) 0.03
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.73
Current Ratio 5.51

Balance Sheet (mrq) ($M)
Current Assets 122.34
Assets 155.29
Liabilities 191.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 185.36
Operating Income 28.66
Net Income 3.32

Cash Flow Statement (mra) ($M)
Cash From Operations 26.88
Cash from Investing -2.71
Cash from Financing -14.38

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Roystone Capital Management LP 6.90 -23.50
02-13 13G/A Bandera Partners LLC 5.40 9.54
02-13 13G/A Boston Partners 2.45 -15.85
02-12 13G/A LMR Partners LLP 0.00 -100.00
06-15 13D 325 Capital Llc 18.70

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 12,977 46,555 27.87
2024-05-01 9,216 89,886 10.25
2024-04-30 8,217 26,528 30.97
2024-04-29 10,919 29,822 36.61

(click for more detail)

Similar Companies
AXSM – Axsome Therapeutics, Inc. BCAB – BioAtla, Inc.
BIOR – Biora Therapeutics, Inc. CADL – Candel Therapeutics, Inc.
CARA – Cara Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io